Penumbra PEN
NYSE PEN
$319.75 +0.49 (+0.15%)
As of: Sep 9, 2026 · 1:49 PM EDT

Penumbra (PEN) Other Non Operating Income (2014 - 2023)

Penumbra's (PEN) quarterly Other Non Operating Income came in at -$444000.0 in Q3 2023, up 81.15% year-over-year from -$245094.7 in Q3 2022, and down 154.95% quarter-over-quarter from $808000.0 in Q2 2023.

Analysis

Penumbra (PEN) Other Non Operating Income (2014 - 2023) Analysis & Trends

Penumbra (PEN) has reported Other Non Operating Income for 10 consecutive years, with -$444000.0 the latest figure, recorded in Q3 2023.

  • On a quarterly basis, Other Non Operating Income rose 81.15% year-over-year to -$444000.0 in Q3 2023; TTM through Sep 2023 was $2.4 million, a 146.75% increase from a year earlier, with the FY2022 full-year figure at -$2.3 million, up 40.92% from the prior year.
  • Other Non Operating Income was -$444000.0 for Q3 2023 at Penumbra, down from $808000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $2.0 million in Q4 2022 and troughed at -$2.4 million in Q3 2022.
  • A 5-year average of -$335894.7 and a median of -$408000.0 in 2021 frame the typical range for Other Non Operating Income.
  • Across the five-year window, Other Non Operating Income soared 1445.45% in 2019 and tumbled 8221.43% in 2021, its largest moves.
  • Over 5 years, Other Non Operating Income stood at $592000.0 in 2019, then soared by 32.94% to $787000.0 in 2020, then slumped by 216.65% to -$918000.0 in 2021, then jumped by 317.43% to $2.0 million in 2022, then plunged by 122.24% to -$444000.0 in 2023.
  • The last three Other Non Operating Income figures came in at -$444000.0 (Q3 2023), $808000.0 (Q2 2023), and $90000.0 (Q1 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.91 Bn 178.31 Bn 7.27 Bn
2 Intuitive Surgical 124.32 Bn 119.11 Bn 1.96 Bn
3 Medtronic 118.42 Bn 109.60 Bn 6.34 Bn
4 Stryker 105.22 Bn 101.74 Bn 4.50 Bn
5 Boston Scientific 66.57 Bn 66.03 Bn 3.85 Bn
6 Edwards Lifesciences 49.76 Bn 45.51 Bn 1.35 Bn
7 Alcon 33.91 Bn 32.46 Bn 1.68 Bn
8 Dexcom 32.28 Bn 30.33 Bn 830.00 Mn
9 Steris 21.10 Bn 20.62 Bn 684.20 Mn
10 Penumbra 12.58 Bn 11.93 Bn 264.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -444,000.00
Jun 30, 2023 808,000.00
Mar 31, 2023 90,000.00
Dec 31, 2022 2.00 Mn
Sep 30, 2022 -2.36 Mn
Jun 30, 2022 -956,000.00
Mar 31, 2022 -1.01 Mn
Dec 31, 2021 -918,000.00
Sep 30, 2021 -1.14 Mn
Jun 30, 2021 -408,000.00
Mar 31, 2021 -1.48 Mn
Dec 31, 2020 787,000.00
Sep 30, 2020 14,000.00
Jun 30, 2020 511,000.00
Mar 31, 2020 -1.66 Mn
Dec 31, 2019 592,000.00
Sep 30, 2019 -772,000.00
Jun 30, 2019 -71,000.00
Mar 31, 2019 24,000.00
Dec 31, 2018 -44,000.00